You need to sign in or sign up before continuing.
Other sphingolipidosis digital illustration

Other sphingolipidosis Save


ICD-10 code: E75.29

Chapter: Endocrine, nutritional and metabolic diseases

Understanding Other Sphingolipidosis: Symptoms, Diagnosis, and Treatment

While Gaucher disease is the most common type of sphingolipidosis, there are several other types that can cause significant health problems. Sphingolipidosis is a group of inherited metabolic disorders that affect the body's ability to break down certain fats called sphingolipids. These fats build up in the cells, leading to damage and dysfunction in various organs and tissues.

  1. Niemann-Pick Disease: This rare genetic disorder is caused by the deficiency of an enzyme called acid sphingomyelinase. This enzyme is responsible for breaking down a fatty substance called sphingomyelin. The buildup of sphingomyelin in the liver, spleen, and brain can lead to organ damage and neurological problems. Symptoms may include enlarged liver and spleen, respiratory problems, and developmental delays. There is currently no cure for Niemann-Pick disease, and treatment focuses on managing symptoms.
  2. Fabry Disease: This X-linked genetic disorder is caused by the deficiency of an enzyme called alpha-galactosidase A. This enzyme is responsible for breaking down a fatty substance called globotriaosylceramide. The buildup of globotriaosylceramide in the blood vessels can cause damage to the kidneys, heart, and nervous system. Symptoms may include pain in the hands and feet, skin rash, and gastrointestinal problems. Treatment may involve enzyme replacement therapy or medications to manage symptoms.
  3. Krabbe Disease: This rare genetic disorder is caused by the deficiency of an enzyme called galactocerebrosidase. This enzyme is responsible for breaking down a fatty substance called galactocerebroside. The buildup of galactocerebroside in the brain can cause damage to the myelin sheath that covers nerve cells. Symptoms may include developmental delays, muscle weakness, seizures, and vision and hearing loss. There is currently no cure for Krabbe disease, and treatment focuses on managing symptoms.

Diagnosis of other sphingolipidosis may involve blood tests, genetic testing, and imaging studies. Treatment options are limited and often focus on managing symptoms and preventing complications. Enzyme replacement therapy may be an option for some types of sphingolipidosis. Genetic counseling may also be recommended for individuals with a family history of these disorders.

Overall, understanding other sphingolipidosis is crucial for early diagnosis and management of symptoms. If you or a loved one has symptoms of any of these disorders, it's important to consult a healthcare professional for proper evaluation and treatment.

Diagnosis Codes for Other sphingolipidosis | E75.29